BR100 Decreased By (-0.92%)
BR30 Decreased By (-1.53%)
KSE100 Decreased By (-0.76%)
KSE30 Decreased By (-0.74%)
AGHA 6.67 Decreased By ▼ -0.01 (-0.15%)
BECO 4.35 Decreased By ▼ -0.02 (-0.46%)
BML 56.07 Decreased By ▼ -1.25 (-2.18%)
BOP 30.05 Decreased By ▼ -0.30 (-0.99%)
CNERGY 12.91 Decreased By ▼ -0.21 (-1.6%)
CSIL 5.35 Decreased By ▼ -0.06 (-1.11%)
FCCL 52.00 Decreased By ▼ -0.79 (-1.5%)
FFL 14.48 Decreased By ▼ -0.24 (-1.63%)
FNEL 1.21 Increased By ▲ 0.09 (8.04%)
KEL 6.10 Increased By ▲ 0.01 (0.16%)
KOSM 5.95 Increased By ▲ 0.22 (3.84%)
LOTCHEM 26.15 Decreased By ▼ -0.31 (-1.17%)
MLCF 91.29 Decreased By ▼ -1.87 (-2.01%)
NBP 163.50 Decreased By ▼ -1.16 (-0.7%)
NCPL 53.20 Decreased By ▼ -2.46 (-4.42%)
NPL 58.23 Decreased By ▼ -2.93 (-4.79%)
OGDC 313.65 Decreased By ▼ -3.08 (-0.97%)
PACE 9.65 Decreased By ▼ -0.22 (-2.23%)
PAEL 35.10 Decreased By ▼ -0.53 (-1.49%)
PIBTL 14.67 Decreased By ▼ -0.01 (-0.07%)
PPL 220.98 Decreased By ▼ -5.93 (-2.61%)
PRL 90.99 Decreased By ▼ -2.03 (-2.18%)
PTC 59.05 Decreased By ▼ -1.21 (-2.01%)
SSGC 23.23 Decreased By ▼ -0.58 (-2.44%)
TBL 8.80 Increased By ▲ 0.05 (0.57%)
TELE 7.58 Decreased By ▼ -0.22 (-2.82%)
TPL 21.94 Decreased By ▼ -0.41 (-1.83%)
TPLP 12.57 Decreased By ▼ -0.40 (-3.08%)
TREET 21.70 Decreased By ▼ -0.46 (-2.08%)
TRG 56.30 Decreased By ▼ -0.26 (-0.46%)
World

Sweden to resume AstraZeneca jabs for over 65s

  • The vaccine is of great use for the elderly, among whom many fall seriously ill each day.
  • "At the same time, we haven't seen these rare and serious side effects among our elderly. That is the background to why we are lifting the suspension for people older than 65."
Published Updated

STOCKHOLM: Sweden will resume use of AstraZeneca's COVID-19 vaccine for people aged 65 and older, the health agency said on Thursday, but keep the pause in place for younger Swedes as it continues to investigate a potential link between the shots and rare cases of blood clots.

"The vaccine is of great use for the elderly, among whom many fall seriously ill each day," Director General Johan Carlson said in a statement on the agency's new guidelines to the regional authorities administering the vaccinations in Sweden.

"At the same time, we haven't seen these rare and serious side effects among our elderly. That is the background to why we are lifting the suspension for people older than 65."

Most countries which temporarily suspended the vaccine have now resumed administering shots following recommendations from the European Union's drug watchdog and the World Health Organization (WHO).

Both the European Medicines Agency (EMA) and the WHO said last week that the benefits of AstraZeneca's vaccine outweighed the risks.

Reuters

Comments

Comments are closed for this article.